Financial Statements - Solvay

More documents

Recommendations

Info

120 Solvay Global Annual Report 2008 List of fully consolidated Group companies Indicating the percentage holding, followed by the Sector. It should be noted that the percentage of voting rights is very close to the percentage holding. Ch = Chemicals Ph = Pharmaceuticals Pl = Plastics - = not allocated BELGIUM Financière Keyenveld SA, Bruxelles (liquidation in progress) 50.4 - Innogenetics NV, Gent 100 Ph Mutuelle Solvay SCS, Bruxelles 99.9 - Peptisyntha SA, Neder-Over-Heembeek 100 Ch Solvay Benvic & Cie Belgium SNC, Bruxelles 100 Pl Solvay Chemicals International SA, Bruxelles 100 Ch Solvay Chemie SA, Bruxelles 100 Ch Solvay Coordination Internationale des Crédits Commerciaux (CICC) SA, Bruxelles 100 - Solvay Nafta Development and Financing SA, Bruxelles 100 - Solvay Participations Belgique SA, Bruxelles 100 - Solvay Pharma SA, Bruxelles 100 Ph Solvay Pharmaceuticals SA - Management Services, Bruxelles 100 Ph Solvay Specialties Compounding SA, Bruxelles 100 - Solvay Stock Option Management SPRL, Bruxelles 100 - Solvic SA, Bruxelles 75 Pl SolVin SA, Bruxelles 75 Pl LUXEMBOURG Solvay Finance (Luxembourg) SA, Luxembourg 100 - Solvay Pharmaceuticals Sarl, Luxembourg 100 Ph NETHERLANDS Physica BV, Weesp 100 Ph Sodufa BV, Weesp 100 Ph Sodufa Pharmaceuticals BV, Weesp 100 Ph Sodufa Biologicals BV, Weesp 100 Ph Solvay Chemicals and Plastics Holding BV, Weesp 100 - Solvay Chemie BV, Linne-Herten 100 Ch Solvay Finance BV, Weesp 100 - Solvay Holding Nederland BV, Weesp 100 - Solvay Pharma BV, Weesp 100 Ph Solvay Pharmaceuticals BV, Weesp 100 Ph SolVin Holding Nederland BV, Weesp 75 Pl FRANCE Fournier Industrie et Santé SA, Dijon 100 Ph Laboratoires Fournier SA, Dijon 100 Ph Solvay Benvic France SAS, Paris 100 Pl Solvay - Carbonate - France SAS, Paris 100 Ch Solvay - Electrolyse - France SAS, Paris 100 Ch Solvay Energie France SAS, Paris 100 - Solvay Finance France SA, Paris 100 - Solvay Finance SA, Paris 100 - Solvay - Fluorés - France SAS, Paris 100 Ch Solvay - Organics - France SAS, Paris 100 Ch Solvay - Olefi nes - France SAS, Paris 100 Pl Solvay Participations France SA, Paris 100 - Solvay Pharma SAS, Suresnes 99.9 Ph Solvay Pharmaceuticals SAS, Suresnes 100 Ph Solvay Solexis SAS, Paris 100 Pl Solvay - Spécialités - France SAS, Paris 100 Ch
SolVin France SA, Paris 75 Pl Vivalsol SNC, Paris 100 Ph ITALY SIS Italia SpA, Rosignano 100 - Società Elettrochimica Solfuri e Cloroderivati (ELESO) SpA, Milano 100 Ch Società Generale per l’Industria della Magnesia (SGIM) SpA, Angera 100 Ch Solvay Bario e Derivati SpA, Massa 100 Ch Solvay Benvic - Italia SpA, Rosignano 100 Pl Solvay Chimica Italia SpA, Milano 100 Ch Solvay Chimica Bussi SpA, Rosignano 100 Ch Solvay Fluor Italia SpA, Rosignano 100 Ch Solvay Finanziaria SpA, Milano 100 - Solvay Padanaplast SpA, Roccabianca 100 Pl Solvay Pharma SpA, Grugliasco 100 Ph Solvay Solexis SpA, Milano 100 Pl SolVin Italia SpA, Ferrara 75 Pl GERMANY Cavity GmbH & Co KG, Hannover 100 Ch Fournier Pharma GmbH, Thansau 100 Ph Girindus AG, Bensberg 75 Ch Kali-Chemie AG, Hannover 100 - Salzgewinnungsgesellschaft Westfalen mbH & Co KG, Epe 65 Ch Solvay GmbH, Hannover 100 - Solvay Advanced Polymers GmbH, Hannover 100 Pl Solvay Arzneimittel GmbH, Hannover 100 Ph Solvay Chemicals GmbH, Hannover 100 Ch Solvay Fluor GmbH, Hannover 100 Ch Solvay Infra Bad Hoenningen GmbH, Hannover 100 Ch Solvay Interox Bitterfeld GmbH, Bitterfeld 100 Ch Solvay Kali-Chemie Holding GmbH 100 - Solvay Organics GmbH, Hannover 100 Ch Solvay Pharmaceuticals GmbH, Hannover 100 Ph Solvay Verwaltungs-und Vermittlungs GmbH, Hannover 100 - SolVin GmbH & Co KG, Hannover 75 Pl SolVin Holding GmbH, Hannover 75 Pl SPAIN Electrolisis de Torrelavega AEI, Torrelavega 100 Ch Hispavic Iberica SL, Martorell 75 Pl Solvay Benvic Iberica SA, Barcelona 100 Pl Solvay Fluor Iberica SA, Tarragona 100 Ch Solvay Ibérica SL, Barcelona 100 - Solvay Participaciones SA, Barcelona 100 - Solvay Pharma SA, Barcelona 100 Ph Solvay Quimica SL, Barcelona 100 Ch Vinilis SA, Martorell 75 Pl SWITZERLAND Solvay (Schweiz) AG, Zurzach 100 Ch Solvay Pharmaceuticals Marketing & Licensing AG, Allschwil 100 Ph Solvay Pharma AG, Bern 100 Ph PORTUGAL 3S Solvay Shared Services-Sociedade de Serviços Partilhados Unipessoal Lda, Carnaxide 100 - Solvay Farma Lda, Porto Salvo 100 Ph Solvay Interox - Produtos Peroxidados SA, Povoa 100 Ch Solvay Portugal - Produtos Quimicos SA, Povoa 100 Ch Voxfarma, Produtos Farmaceuticos, Unipessoal, Lda, Porto Salvo 100 Ph Financial 121 Solvay Global Annual Report 2008 Financial
Page 1 and 2:
Managing Challenges Solvay Global A
Page 3 and 4:
Key fi gures - Solvay Group Financi
Page 5 and 6:
February 1 Caprolactones Solvay con
Page 7 and 8:
Apart from increasing our competiti
Page 9 and 10:
and optional overtime and taking of
Page 11 and 12:
... and Long-Term Value Creation Th
Page 13 and 14:
and using it without limits, the pi
Page 15 and 16:
Chemicals Sales: EUR 3.1 billion -
Page 17 and 18:
2008 : operating result down 19% on
Page 19 and 20:
EUR million 2007 2008 2008/2007 GRO
Page 21 and 22:
Balance sheet Total Equity stood at
Page 23 and 24:
Current profi t before taxes amount
Page 25 and 26:
Robot in Weesp. This 384 wells plat
Page 27 and 28:
Key fi gures [EUR million] 2006 200
Page 29 and 30:
Flagship Products in 2008 Therapeut
Page 31 and 32:
Sales of less important products In
Page 33 and 34:
Sodium bicarbonate. Sodium bicarbon
Page 35 and 36:
Page 37 and 38:
natural resources and limit waste d
Page 39 and 40:
The Organic cluster: Molecular Solu
Page 41 and 42:
Solvay specialty polymers The outst
Page 43 and 44:
Page 45 and 46:
Technological leadership through Re
Page 47 and 48:
production capacities have been inc
Page 49 and 50:
New Business Development OLED. Orga
Page 51 and 52:
future) reacts with atmospheric oxy
Page 53 and 54:
Increasing cultural diversity. Solv
Page 55 and 56:
New career management process In 20
Page 57 and 58:
The 5x5 Matrix The 5x5 Matrix is th
Page 59 and 60:
Investors: responding to growing in
Page 61 and 62:
Financial Statements The following
Page 63 and 64:
Consolidated balance sheet EUR Mill
Page 65 and 66:
Minority interests The increase in
Page 67 and 68:
• IFRIC 15 Agreements for the con
Page 69 and 70:
9. Research and Development costs R
Page 71 and 72:
Key assumptions & key sources of es
Page 73 and 74: General description of the segments
Page 75 and 76: Information per primary segment for
Page 77 and 78: For the Pharmaceuticals Sector, whi
Page 79 and 80: - Current tax represents the tax pa
Page 81 and 82: Other information All the Group’s
Page 83 and 84: The acquisitions in 2008 consist ma
Page 85 and 86: Alexandria Sodium Carbonate On 17 O
Page 87 and 88: (20) Capital increase / redemption
Page 89 and 90: Consolidated balance sheet (22) Int
Page 91 and 92: (24) Tangible assets (including fi
Page 93 and 94: (26) Other investments EUR million
Page 95 and 96: (29) Provisions EUR Million Employe
Page 97 and 98: The amounts recorded in the balance
Page 99 and 100: Actuarial assumptions used in deter
Page 101 and 102: - the risks attached to ongoing lit
Page 103 and 104: Fair value of fi nancial debts For
Page 105 and 106: ) Balance sheet risk The Group’s
Page 107 and 108: Financial instruments IAS 39 defi n
Page 109 and 110: (32) Assets held for sale and liabi
Page 111 and 112: Management of Risks Acting responsi
Page 113 and 114: In reference to Raw Materials, in a
Page 115 and 116: Since 2007 a compliance organizatio
Page 117 and 118: Participation in venture capital fu
Page 119 and 120: Compensation report 1. Description
Page 121 and 122: affi liated to the Pension Regulati
Page 123: Companies leaving the Group Country
Page 127 and 128: Solvay Soda Ash Joint Venture, Hous
Page 129 and 130: FINLAND Pipelife Finland OY, Oulu 5
Page 131 and 132: Summary fi nancial statements of So
Page 133 and 134: STATUTORY AUDITOR’S REPORT To the
Page 135 and 136: Report on the application of the Co
Page 137 and 138: Introduction This report presents t
Page 139 and 140: The Board of Directors noted their
Page 141 and 142: notice of the meeting by mail at th
Page 143 and 144: Year of birth Year of 1st appointme
Page 145 and 146: eing a non-executive director of a
Page 147 and 148: 4.5.2. The Audit Committee At Janua
Page 149 and 150: corresponding to the decision or re
Page 151 and 152: which remained valid for the 2008 f
Page 153 and 154: Manager, a member of the Executive
Page 155 and 156: EUR The Solvay share compared with
Page 157 and 158: ANNEX 1 Audit Committee Mission Sta
Page 159 and 160: during the 30 days preceding the st
Page 161 and 162: Executive Committee 1 | Christian J
Page 163 and 164: ABAF: Belgian Financial Analysts As
Page 165 and 166: Shareholders’ Diary - Tuesday May
show all

Financial Statements - Solvay

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?